Small-Cap Snapshot: Cool Holdings buys Simply Mac chain; So-called 'Amazon of Africa' falls on Citron report

Other small-caps making moves include Cars.com, Creative Realities and TransEnterix

Nasdaq building
Simply Mac is the largest Apple Premier Partner in the US, with 43 stores in 18 states


Shares of Cool Holdings Inc (NASDAQ:AWSM) announced it was buying the Simply Mac chain of Apple Inc (NASDAQ:AAPL) retail and repair stores. Simply Mac is the largest Apple Premier Partner in the US, with 43 stores in 18 states.

The stock jumped nearly 21% to $2.80.

Cars.com Inc (NYSE:CARS) had first-quarter earnings that came in ahead of Street expectations Friday morning as brand awareness hit an all-time high. The online vehicle marketplace saw adjusted net income fall 27% to $20.7 million, or $0.31 per share. That crushed analyst expectations of $0.04 per share.

Shares sped ahead 4.5% to $21.76.

Creative Realities Inc (NASDAQ:CREX), a digital marketing company, posted first-quarter revenue late Wednesday that more than doubled year over year. The company brought in revenue of $9.5 million, up from $4.1 million a year ago.

The stock climbed nearly 10% to $2.62.

READ: Buds & Duds: Cannabis stocks flat on Friday; Next Green Wave shares surge

Westport Fuel systems Inc (NASDAQ:WPRT), the manufacturer of clean fuel systems, reported first-quarter results that came in ahead of expectations, and won an analyst upgrade as a result.

Shares fueled up 22% to $2.04.


Jumia Technologies AG (NYSE:JMIA) shares sank after Citron Research’s Andrew Left, a noted short seller, alleged in a report that it has the “smoking gun” that shows why Jumia equity is “worthless.”

The stock plunged 24% to $20.29.

Robotic surgery company TransEnterix Inc (NYSEAMERICAN:TRXC) dropped in response to the company's rough first-quarter earnings report late Thursday. The company missed Wall Street's consensus estimate for its EPS by 10% and whiffed on revenue by a staggering 62% for the period.

Shares collapsed 38% to $1.30.

Puma Biotechnology Inc (NASDAQ:PBYI) plunged on Friday after the company revealed that more patients than expected were discontinuing treatment with its breast cancer drug, Nerlynx, spurring a sharp drop in sales and prompting several analysts to downgrade the company's stock.

The stock plummeted 37% to $18.78.

Melinta Therapeutics Inc (NASDAQ:MLNT) on Thursday reported a loss of $26.5 million in its first quarter. On a per-share basis, the New Haven, Connecticut-based company said it had a loss of $2.34. The drugmaker posted revenue of $14.1 million in the period.

The share price swooned 25% to $3.44.

Contact Andrew Kessel at [email protected]

Follow him on Twitter @andrew_kessel

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: InnoCan Pharma signs deal with ADVA Biotechnology to produce...

InnoCann Pharma (CSE: INNO) CEO Iris Bincovich joined Steve Darling from Proactive Vancouver with news the company has signed a Letter of Intent with ADVA Bio-Technology for exosome manufacturing and development. Bincovich telling Proactive InnoCan intends to load the produced exosomes with...

34 minutes ago

3 min read